0B68 Lau, Wayne Bond - Thomas Jefferson University - Thomas Jefferson University
Wayne Bond Lau

Wayne Bond Lau, MD

Contact Dr. Lau

1020 Sansome Street
Suite 239
Philadelphia, PA 19107

(215) 955-6844
(215) 923-6225 fax

Most Recent Peer-reviewed Publications

  1. Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation
  2. Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes
  3. Extracorporeal membrane oxygenation to support whole-lung lavage in pulmonary alveolar proteinosis salvage of the drowned lungs
  4. Alveolar macrophage cathelicidin deficiency in severe sarcoidosis
  5. Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis
  6. Applied Anatomy of the Airways
  7. Alveolar macrophage activation in obese patients with obstructive sleep apnea
  8. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis
  9. Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes
  10. Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis
  11. Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice
  12. Sleep and metabolism: An overview
  13. Montelukast added to fluticasone propionate does not alter inflammation or outcomes
  14. Targeted PPARγ deficiency in alveolar macrophages disrupts surfactant catabolism
  15. PPARγ regulates the expression of cholesterol metabolism genes in alveolar macrophages
  16. Alveolar proteinosis syndrome: Pathogenesis, diagnosis, and management
  17. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: Comparison of different methods of e 05DC valuation
  18. Deletion of PPARγ in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response
  19. A novel 1,25-dihydroxyvitamin D - Activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP)
  20. Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial